Our view: Infill development critical to meeting housing needs
At a time when hand wringing over the high cost of housing has become more of a political cop out than a panacea, a new study underscores the benefits of infill development. Next 10, a group that relies on interdisciplinary research from UC Berkeley’s law, environmental and business experts, has cited infill housing for many Read More →
Tri-county nonprofits need to adapt, innovate
By Charles Maxey and Linda Kimbrough Trump administration budget proposals should be sending early warning signals to the nation’s nonprofit organizations. The anticipated reductions in federal and, therefore, state spending will adversely impact many populations served by charitable organizations. At the same time, the need for services continues to rise. Nonprofit Finance Fund’s 2014 study Read More →
FDA fast tracks Amgen’s Blincyto leukemia drug
Thousand Oaks-based biotech giant Amgen announced March 29 that the U.S. Food and Drug Administration has fast-tracked the company’s leukemia drug Blincyto for priority review. The drug increases the length of survival among high-risk patients, according to a study released by the New England Journal of Medicine. It almost doubled median overall survival versus chemotherapy among adult patients Read More →
500 Amgen employees to be re-assigned, relocated or laid off
Nearly 500 Amgen employees in Thousand Oaks have been notified that they will be re-assigned, relocated or laid off as part of a restructuring plan. The biotech giant informed employees on March 22 that they will be reassigned to a new Tampa Bay, Fla. facility and research and development offices in Cambridge, Mass. and South Read More →
Amgen gets European approval for biosimilar of Humira
Thousand Oaks-based Amgen has announced that the European Commission has granted marketing authorization for Amgevita, a drug that treats inflammatory diseases, including moderate-to-severe rheumatoid arthritis. The Amgen biosimilar will compete with AbbVie’s blockbuster drug Humira. “The approval of our first biosimilar by the European Commission is a major milestone not just for Amgen as a company, but for the millions Read More →
Teledyne to provide electronics for mission to Jupiter
A French space agency awarded nearly $10 million to a subsidiary of Thousand Oaks-based Teledyne Technologies to provide infrared detectors and electronics for a mission to Jupiter. The Centre National d’Études Spatiales, or CNES, contracted with Teledyne Scientific & Imaging for the products, which are planned to equip a 2022 European Space Agency launch. Over Read More →
Lawsuit over vacation rental ban allowed to continue
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
